BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1445889)

  • 41. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
    Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
    J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of urokinase on cell proliferation and invasion.
    Binder BR
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors.
    Urano T; Sator de Serrano V; Chibber BA; Castellino FJ
    J Biol Chem; 1987 Nov; 262(33):15959-64. PubMed ID: 3680236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.
    Shi GY; Wu HL
    J Biol Chem; 1988 Nov; 263(32):17071-5. PubMed ID: 2972717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of plasminogen activators from human seminal plasma.
    Propping D; Zaneveld LJ; Tauber PF; Schumacher GF
    Biochem J; 1978 May; 171(2):435-44. PubMed ID: 26336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.
    Suenson E; Petersen LC
    Biochim Biophys Acta; 1986 Apr; 870(3):510-9. PubMed ID: 2938632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of heat on the distribution of fluorescently labeled plasminogen and plasminogen activators in bovine skim milk.
    Wang L; Mauer LJ
    J Food Sci; 2008 Apr; 73(3):C185-90. PubMed ID: 18387097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase.
    Wang J; Reich E
    Protein Sci; 1995 Sep; 4(9):1768-79. PubMed ID: 8528075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
    Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
    Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanism of thrombolytic enzymes].
    Matsuo O
    Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and partial characterisation of alpha(2)-antiplasmin and plasmin(ogen) from ostrich plasma.
    Thomas AR; Naudé RJ; Oelofsen W; Naganuma T; Muramoto K
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Jul; 129(4):809-20. PubMed ID: 11435135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.